Debate

DOI: 10.4244/EIJ-E-23-00045

Complete revascularisation should be immediate in STEMI: pros and cons

Adnan Kastrati1,2, MD; Thorsten Kessler1,2, MD; Riccardo Rinaldi3, MD; Salvatore Brugaletta3, MD, PhD

Multivessel coronary artery disease often occurs in patients presenting with ST-segment elevation myocardial infarction (STEMI). Current European guidelines on acute coronary syndromes (ACS) recommend complete revascularisation in such patients, but there is no consensus on the optimal timing. As such, percutaneous coronary intervention (PCI) of the non-infarct-related arteries (IRAs) can be performed either immediately (i.e., during the primary PCI) or in a staged (i.e., within 45 days) procedure. Although an immediate complete revascularisation can reduce the use of contrast medium and radiation and can be more practical in off-hours procedures, there are factors that favour a staged approach, including the high thrombo-inflammatory burden, an impaired evaluation of non-IRAs and the lack of information about patient history and comorbidities. Both these strategies have pros and cons, and the optimal timing for complete revascularisation remains a subject of debate.

Pros

Adnan Kastrati, MD; Thorsten Kessler, MD

Primary PCI with treatment of the culprit lesion is the standard of care for patients with STEMI1. Existing evidence supports the benefits of complete revascularisation (CR) over culprit lesion-only PCI in STEMI with multiple...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 3
Feb 5, 2024
Volume 20 Number 3
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV16I3A34 Jun 25, 2020
Complete revascularisation in the STEMI patient: is it worth the effort?
Gershlick A and Banning AS
free

Original Research

10.4244/EIJ-D-23-00882 Jul 15, 2024
Immediate versus staged complete revascularisation in patients presenting with STEMI and multivessel disease
Scarparo P et al

State-of-the-Art Review

10.4244/EIJ-D-20-00957 Jun 25, 2021
Completeness of revascularisation in acute coronary syndrome patients with multivessel disease
Paradies V et al
free
Trending articles
225.68

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
105.78

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.85

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
68.7

Clinical research

10.4244/EIJ-D-21-00545 Sep 20, 2022
Coronary lithotripsy for the treatment of underexpanded stents: the international; multicentre CRUNCH registry
Tovar Forero M et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
45.3

Clinical research

10.4244/EIJ-D-18-01126 Aug 29, 2019
New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis
Ameloot K et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved